113 related articles for article (PubMed ID: 22989984)
21. Conjugates of poly(DL-lactide-co-glycolide) on amino cyclodextrins and their nanoparticles as protein delivery system.
Gao H; Wang YN; Fan YG; Ma JB
J Biomed Mater Res A; 2007 Jan; 80(1):111-22. PubMed ID: 16960831
[TBL] [Abstract][Full Text] [Related]
22. BSA degradation under acidic conditions: a model for protein instability during release from PLGA delivery systems.
Estey T; Kang J; Schwendeman SP; Carpenter JF
J Pharm Sci; 2006 Jul; 95(7):1626-39. PubMed ID: 16729268
[TBL] [Abstract][Full Text] [Related]
23. Concomitant monitoring of implant formation and drug release of in situ forming poly (lactide-co-glycolide acid) implants in a hydrogel matrix mimicking the subcutis using UV-vis imaging.
Sun Y; Jensen H; Petersen NJ; Larsen SW; Østergaard J
J Pharm Biomed Anal; 2018 Feb; 150():95-106. PubMed ID: 29216591
[TBL] [Abstract][Full Text] [Related]
24. Preparation, characterization and in-vitro evaluation of sustained release protein-loaded nanoparticles based on biodegradable polymers.
Mukherjee B; Santra K; Pattnaik G; Ghosh S
Int J Nanomedicine; 2008; 3(4):487-96. PubMed ID: 19337417
[TBL] [Abstract][Full Text] [Related]
25. Nerve guidance channels as drug delivery vehicles.
Piotrowicz A; Shoichet MS
Biomaterials; 2006 Mar; 27(9):2018-27. PubMed ID: 16239029
[TBL] [Abstract][Full Text] [Related]
26. Effect of PLGA as a polymeric emulsifier on preparation of hydrophilic protein-loaded solid lipid nanoparticles.
Xie S; Wang S; Zhao B; Han C; Wang M; Zhou W
Colloids Surf B Biointerfaces; 2008 Dec; 67(2):199-204. PubMed ID: 18829272
[TBL] [Abstract][Full Text] [Related]
27. A protein delivery system: biodegradable alginate-chitosan-poly(lactic-co-glycolic acid) composite microspheres.
Zheng CH; Gao JQ; Zhang YP; Liang WQ
Biochem Biophys Res Commun; 2004 Oct; 323(4):1321-7. PubMed ID: 15451441
[TBL] [Abstract][Full Text] [Related]
28. Preparation, characterization and in vivo pharmacodynamic evaluation of thymopentin loaded poly(lactide acid)/poly(lactide-co-glycolide acid) implants.
Wei G; Jin L; Xu L; Liu Y; Lu W
Int J Pharm; 2010 Oct; 398(1-2):123-9. PubMed ID: 20674730
[TBL] [Abstract][Full Text] [Related]
29. Influence of the test method on in vitro drug release from intravitreal model implants containing dexamethasone or fluorescein sodium in poly (d,l-lactide-co-glycolide) or polycaprolactone.
Stein S; Auel T; Kempin W; Bogdahn M; Weitschies W; Seidlitz A
Eur J Pharm Biopharm; 2018 Jun; 127():270-278. PubMed ID: 29490233
[TBL] [Abstract][Full Text] [Related]
30. Incorporation and in vitro release of doxorubicin in thermally sensitive micelles made from poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide)-b-poly(D,L-lactide-co-glycolide) with varying compositions.
Liu SQ; Tong YW; Yang YY
Biomaterials; 2005 Aug; 26(24):5064-74. PubMed ID: 15769542
[TBL] [Abstract][Full Text] [Related]
31. Facile control of porous structures of polymer microspheres using an osmotic agent for pulmonary delivery.
Lee J; Oh YJ; Lee SK; Lee KY
J Control Release; 2010 Aug; 146(1):61-7. PubMed ID: 20553775
[TBL] [Abstract][Full Text] [Related]
32. Molecular mechanism of improved structural integrity of protein in polymer based microsphere delivery system.
Rawat S; Kohli N; Suri CR; Sahoo DK
Mol Pharm; 2012 Sep; 9(9):2403-14. PubMed ID: 22724678
[TBL] [Abstract][Full Text] [Related]
33. Fluphenazine release from biodegradable microparticles: characterization and modelling of release.
Dunne MM; Ramtoola Z; Corrigan OI
J Microencapsul; 2009 Aug; 26(5):403-10. PubMed ID: 18785053
[TBL] [Abstract][Full Text] [Related]
34. Influence of PLGA End Groups on the Release Profile of Dexamethasone from Ocular Implants.
Saraf I; Kushwah V; Alva C; Koutsamanis I; Rattenberger J; Schroettner H; Mayrhofer C; Modhave D; Braun M; Werner B; Zangger K; Paudel A
Mol Pharm; 2023 Feb; 20(2):1307-1322. PubMed ID: 36680524
[TBL] [Abstract][Full Text] [Related]
35. Enhanced surface attachment of protein-type targeting ligands to poly(lactide-co-glycolide) nanoparticles using variable expression of polymeric acid functionality.
McCarron PA; Marouf WM; Donnelly RF; Scott C
J Biomed Mater Res A; 2008 Dec; 87(4):873-84. PubMed ID: 18228271
[TBL] [Abstract][Full Text] [Related]
36. Development and characterization of interleukin-18-loaded biodegradable microspheres.
Lagarce F; Garcion E; Faisant N; Thomas O; Kanaujia P; Menei P; Benoit JP
Int J Pharm; 2006 May; 314(2):179-88. PubMed ID: 16515850
[TBL] [Abstract][Full Text] [Related]
37. Drug-Eluting Biodegradable Implants for the Sustained Release of
Dharmayanti C; Gillam TA; Williams DB; Blencowe A
Polymers (Basel); 2020 Dec; 12(12):. PubMed ID: 33297466
[TBL] [Abstract][Full Text] [Related]
38. USP apparatus 4 method for in vitro release testing of protein loaded microspheres.
Rawat A; Burgess DJ
Int J Pharm; 2011 May; 409(1-2):178-84. PubMed ID: 21376792
[TBL] [Abstract][Full Text] [Related]
39. Paclitaxel releasing films consisting of poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) and their potential as biodegradable stent coatings.
Westedt U; Wittmar M; Hellwig M; Hanefeld P; Greiner A; Schaper AK; Kissel T
J Control Release; 2006 Mar; 111(1-2):235-46. PubMed ID: 16466824
[TBL] [Abstract][Full Text] [Related]
40. Towards the optimization of drug delivery to the cochlear apex: Influence of polymer and drug selection in biodegradable intracochlear implants.
Lehner E; Honeder C; Knolle W; Binder W; Scheffler J; Plontke SK; Liebau A; Mäder K
Int J Pharm; 2023 Aug; 643():123268. PubMed ID: 37488058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
